(Reuters) – Bristol-Myers Squibb Co said it would invest in Dutch biotech uniQure NV , joining other big drugmakers who have moved to gain a foothold in the promising gene therapy market.
UniQure’s shares jumped more than 55 percent on Monday after Bristol-Myers said it would pick up a 4.9 percent stake in the company.
19:34 CEO shift at Coca-Cola could usher in more dealmaking to refresh soda giant's growth12
16:37 Fitbit acquires software assets from rival Pebble14
14:31 Lost Christmas parcels 'prompt two-and-a-half-hour hunt'16
14:49 Trump warns of ‘retribution’ for companies that offshore jobs, threatening 35 percent tariff19